GlassScriptPhysician profile
Amber C Tsang
NPI 1932738010
$2,384.12
in general payments reported to CMS, 2019-2025
12 companies · $1,893 in 2025
The $1,893 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.18 · 2024: $476 · 2025: $1,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,825 · Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,825.00 |
| Food and Beverage | $559.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2025 | |
| Medical Device Business Services, INC. | $325.00 | 2024 | |
| Hologic Sales and Service, LLC | $216.98 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Thinprep 2000 Processor |
| Minerva Surgical, INC | $147.54 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.71 | 2025 | |
| Millicent US INC | $37.56 | 2025 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $20.87 | 2025 | |
| Aspira Women'S Health INC | $19.06 | 2024 | Ova1 |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $18.35 | 2025 | Paragard T 380a |
| Organon LLC | $16.26 | 2025 | Nexplanon |
| Axonics, INC. | $15.18 | 2023 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Tsang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.